| Company Name: |
Wuhan BJM Pharm Inc Gold |
| Tel: |
18607102166 18607102166 |
| Email: |
sales04@benjaminpharmchem.com |
| Company Name: |
INTATRADE GmbH |
| Tel: |
+49 3493/605464 |
| Email: |
sales@intatrade.de |
| Company Name: |
Alfa Aesar |
| Tel: |
400-6106006 |
| Email: |
saleschina@alfa-asia.com |
|
| | 3,5-Dichloroanthranilic acid Basic information | | Synthesis |
| | 3,5-Dichloroanthranilic acid Chemical Properties |
| Melting point | 227-230 °C(lit.) | | Boiling point | 344.4±42.0 °C(Predicted) | | density | 1.4062 (rough estimate) | | refractive index | 1.6100 (estimate) | | storage temp. | Storage temperature: no restrictions. | | solubility | Acetic Acid (Slightly, Heated), DMSO (Slightly) | | form | Solid | | pka | 4.20±0.10(Predicted) | | color | White to Pale Yellow | | Water Solubility | insoluble | | BRN | 779100 | | Major Application | peptide synthesis | | InChI | InChI=1S/C7H5Cl2NO2/c8-3-1-4(7(11)12)6(10)5(9)2-3/h1-2H,10H2,(H,11,12) | | InChIKey | KTHTXLUIEAIGCD-UHFFFAOYSA-N | | SMILES | C(O)(=O)C1=CC(Cl)=CC(Cl)=C1N | | CAS DataBase Reference | 2789-92-6(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-37/39-36 | | WGK Germany | 2 | | RTECS | CB2800000 | | HS Code | 29224985 | | Storage Class | 11 - Combustible Solids | | Toxicity | mouse,LD50,oral,1320mg/kg (1320mg/kg),BEHAVIORAL: EXCITEMENTLUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION,Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 52(6), Pg. 85, 1987. |
| | 3,5-Dichloroanthranilic acid Usage And Synthesis |
| Synthesis | 2-amino-3,5-dichlorobenzoic acid was obtained by chlorination of 2-aminobenzoic acid in HCl . IR (suspension in nujol, cm−1
): 3492, 3372, 1682,
1615, 1575, 1544, 1421, 1402, 1312, 1251, 1227, 1153, 1073, 876, 789. | | Chemical Properties | off-white to yellow to dark pink | | Uses | 2-Amino-3,5-dichlorobenzoic acid, is an important raw material and intermediate used in organic Synthesis, pharmaceuticals, agrochemicals and dyestuff. | | reaction suitability | reaction type: solution phase peptide synthesis |
| | 3,5-Dichloroanthranilic acid Preparation Products And Raw materials |
| Preparation Products | 2-Amino-5-chlorobenzoic acid-->6-amino-10,12-dichloronaphth[2,3-c]acridine-5,8,14(13H)-trione-->Pyrrolo[2,1-b]quinazolin-9(1H)-one, 5,7-dichloro-2,3-dihydro--->6,8-dichloro-2-methyl-3,1-benzoxazin-4-one-->2-Bromo-3,5-dichloro-benzoic acid |
|